Skip to main content

Find Clinical Trials

Home
Conditions
Breast Neoplasms, Male

Clinical trial condition

Breast Neoplasms, Male

Explore clinical trials studying Breast Neoplasms, Male. Study availability and eligibility vary by location and protocol.

213 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms, Male trial results

Completed

Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

NCT00007891

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Cancer Research Institute of Contra Costa San Francisco, California, United States

University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer

NCT00006370

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

NCT00897793

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +59 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00089362

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

NCT00304096

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +11 more
Locations: University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

NCT00680758

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Sarah Cannon Cancer Center at Centennial Medical Center Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Biological Therapy in Treating Patients With Metastatic Cancer

NCT00004604

Conditions: Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +92 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details